TAE Life Sciences is a biotechnology company focused on revolutionizing cancer treatment through its proprietary Boron Neutron Capture Therapy (BNCT) technology. The company was spun out from TAE Technologies in 2017 and is dedicated to developing and commercializing biologically targeted radiotherapy to improve the lives of cancer patients.
Notable Investments
